Vision2Voice
Case Study: KOL Identification in Late-Stage Clinical Trials
A BioPharma client had an orphan drug used to treat a rare endocrine disorder in late-stage clinical trials, but no existing network of Key Opinion Leaders (KOLs)…
Vision2Voice
When and Why Simple Might Be Better for KOL Identification & Mapping
Identifying and mapping the right Key Opinion Leaders (KOLs) is the foundational tactic that lays the groundwork for your peer-to-peer strategies that follow, whether conducting advisory boards or building a speaker’s bureau. KOLs are critical to educating healthcare practitioners (HCPs) who will ultimately deliver your product to the patients who Read more…
Vision2Voice
How to Keep Advisory Boards Simple – Dan Recommends
When done right, advisory boards are exhilarating. We often gain insights and new ways of thinking from key opinion leaders (KOLs) that we likely never considered. In the hundreds of advisory boards I’ve been a part of through the years, I’ve been able to watch the greatest minds present complex Read more…
Vision2Voice
Trust is a Two-Way Street
Recent news headlines have spotlighted how unethical and irresponsible behavior on the part of pharma companies and their agencies can breach public trust…
